MedTrace Logo

Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)

NCT02435303 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2019-07-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether Sildenafil is effective in the treatment of sustained pulmonary artery hypertension after corrected mitral valve disease.

Conditions

  • Hypertension, Pulmonary
  • Diseases of Mitral Valve

Interventions

DRUG

Sildenafil

DRUG

Placebo

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Jong-Min Song · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-06-30
Completion
2018-06-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02435303 on ClinicalTrials.gov